Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-25 @ 8:22 PM
Study NCT ID:
NCT05263869
Status:
UNKNOWN
Last Update Posted:
2022-12-02
First Post:
2022-02-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients
Sponsor:
Shanghai Miracogen Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-21
First Submit QC Date:
None
Study First Post Date:
2022-03-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-29
Last Update Post Date:
2022-12-02
Last Update Post Date Type:
ACTUAL